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Abstract
Most genetic association studies only genotype a small proportion of cataloged single-nucleotide
polymorphisms (SNPs) in regions of interest. With the catalogs of high-density SNP data available
(e.g., HapMap) to researchers today, it has become possible to impute genotypes at untyped SNPs.
This in turn allows us to test those untyped SNPs, the motivation being to increase power in
association studies. Several imputation methods and corresponding software packages have been
developed for this purpose. The objective of our study is to apply three widely used imputation
methods and corresponding software packages to a data from a genome-wide association study of
rheumatoid arthritis from the North American Rheumatoid Arthritis Consortium in Genetic
Analysis Workshop 16, to compare the performances of the three methods, to evaluate their
strengths and weaknesses, and to identify additional susceptibility loci underlying rheumatoid
arthritis. The software packages used in this paper included a program for Bayesian imputation-
based association mapping (BIMBAM), a program for imputing unobserved genotypes in case-
control association studies (IMPUTE), and a program for testing untyped alleles (TUNA). We found
some untyped SNP that showed significant association with rheumatoid arthritis. Among them, a
few of these were not located near any typed SNP that was found to be significant and thus may be
worth further investigation.
Background
Advances in the understanding of a disease’s pathogenesis
often lead to improvements in strategy for the prevention,
diagnosis, and/or treatment of the disease. Moreover,
studies have shown that genetic factors play an important
role in the pathogenesis of many complex human diseases.
Therefore, improving public health and preventing disease
provides sufficient motivation for dissecting the genetic
etiology of complex human diseases. The genome-wide
association study (GWAS) may be seen as a first step
towards such dissections and have drawn considerable
attention (with some success) in recent years.
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Open AccessIndeed, many GWAS have resulted in identifying at least
one candidate gene that may seem likely, considering the
biological properties of the gene, to have an effect on the
disease [1]. In a typical GWAS, a large number of
population samples of cases and controls are genotype at
hundreds of thousands of single-nucleotide polymorph-
isms (SNPs). However, even at these numbers, the SNPs
that are genotyped in GWAS will only account for a
small proportion of cataloged SNPs. In particular, it is
likely that disease susceptibility variants are not directly
assayed. With the availability of a high-density panel of
SNPs such as from HapMap [2], it is possible to gain
additional power by testing untyped SNPs based on data
at the genotyped SNPs. Testing untyped SNPs can
facilitate the selection of SNPs to be genotyped in
follow-up studies and can allow for comparison of
findings or joint analysis of data from different studies
that use different SNP panels and genotyping platforms.
Several methods have recently been developed and their
corresponding software packages implemented to test
untyped SNPs [3-5]. Although these methods differ in
specific strategies used to impute genotypes at untyped
SNPs, they generally follow three steps. In the first step,
linkage disequilibrium (LD) patterns are dissected and/
or haplotypes and their frequencies are inferred from
genotypes of reference samples, such as genotypes from
the HapMap project. In the second step, genotypes at
untyped SNPs are imputed based on genotypes in
observed data and their correlation with typed SNPs in
reference samples. In the final step, association tests are
performed on all typed and untyped SNPs. In this paper,
we selected three software packages based on imputation
methods, including Bayesian imputation-based associa-
tion mapping (BIMBAM), imputing unobserved geno-
types in case-control association studies (IMPUTE), and
testing untyped alleles (TUNA) to analyze data from a
GWAS of rheumatoid arthritis (RA) from North Amer-
ican Rheumatoid Arthritis Consortium (NARAC) pro-
vided to Genetic Analysis Workshop 16 (GAW16). These
software packages were selected in this study because
they are publicly available and can readily perform
imputations and association tests in a genome-wide
scale. We report our findings, compare the performances




The case-control data was obtained from the NARAC
provided for GAW16. It contains genotypes of NARAC
(868 cases and 1,194 controls at 545,080 SNPs) after
removing duplicated and contaminated samples.
B e c a u s et h et h r e es o f t w a r ep a c k a g e sw e r ei m p l e m e n t e d
for autosomes, only SNPs from 22 autosomes were used.
SNPs with minor allele frequency (MAF) less than 0.01
and SNPs with p-value of Hardy-Weinberg equilibrium
test in controls less than 0.0001 were removed. A total of
515,050 SNPs remained in our analysis. The Phase II
genotype data of 60 CEU samples from the HapMap
project http://www.hapmap.org/ was downloaded and
used as reference data to impute genotypes at untyped
SNPs.
BIMBAM
BIMBAM [6] uses the methods implemented in fast-
PHASE [5] to impute the genotypes at untyped SNPs.
The Bayes factors (BFs) are computed under linear or
logistic regression of phenotypes on genotypes. Specifi-
cally, for binary (0/1) phenotypes, the BFs are computed
under a logistic regression model, logit(Pr(Yi =1 ) )=l o g
(Pr(Yi =1 ) / P r ( Yi =0 ) )=μ + aXi + dI(Xi =1 ) ,w h e r eYi
denotes the phenotype for individual i, Xi denotes the
genotype for individual i (coded as 0, 1, or 2), a denotes
the additive effect, and d denotes the dominance effect.
T h eB F sa r ec o m p u t e du n d e rt h es a m ep r i o r sf o rμ, a,a n d
d as in prior D2 [5].
IMPUTE
The computer program IMPUTE [7] uses a hidden
Markov Model to determine the genotype probabilities
for each individual in the study at untyped SNPs that are
available in reference samples. The Cochran-Armitage
trend test for associations is then implemented on the
resulting file using the software SNPTEST [3]. A key
feature of IMPUTE is that it can use genotype probabil-
ities rather than deterministic genotypes. The test of
additive association was used in our analysis.
TUNA
The imputation-based analysis implemented in TUNA
[8] uses a multi-locus measure of LD, similar in
interpretation to r
2, to determine the best set of
genotyped markers that can be used for estimating the
genotype frequencies of an untyped SNP in cases and
controls separately. The statistical test for association
implemented in TUNA aims to find differences in the
allele frequencies in cases and controls [4]. It has an
asymptotic chi-square distribution with one degree of
freedom under the null hypothesis.
Simulation study
Simulations were performed based on haplotypes and
their frequencies of CHI3L2 gene from CEU and YRI
samples from the HapMap. After removing SNPs with
MAF less than 0.05, 25 and 17 SNPs were remained for
CEU and YRI samples, respectively. One SNP with MAF
of about 0.15 was selected as disease SNP and 400 cases
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relative risk of 1.0 (to assess the type I error) or 1.5 (to
assess power) and a prevalence of 0.10. Genotypes at
disease SNP and half of SNPs were removed to test the
performance of imputation methods. The Phase II data
of CEU 60 samples was used as reference, which allows
us to investigate the performance of imputation methods
when the LD pattern was misspecified. The simulation
procedure was repeated 1,000 times.
Results
The final number of typed and untyped SNPs we tested
and the number of significant SNPs are listed in Table 1.
Note that all three software packages automatically
removed some SNPs from the analysis; the total number
of typed SNPs tested was less than the total number of
typed SNPs remaining after the preprocessing step. For
IMPUTE and TUNA, the Bonferroni correction was used
to determine significant SNPs. Specifically, a SNP was
significant if its p- v a l u ew a sl e s st h a n0 . 0 5 / m,w h e r em
was the number of SNPs tested, which was the total
number of typed and imputed untyped SNPs and was
different for different methods. We also set m as the
number of typed SNPs tested to see how many typed
SNPs were significant if only typed SNPs were included
in the analysis. For BIMBAM, a SNP was significant if
(BF) was bigger 3.5, which was comparable to the
log10(BF) of 3.2 used by Servin and Stephens [5]. Several
findings emerge from Table 1. First, notice that TUNA
only tested a small number of untyped SNPs. This is
because TUNA only tests untyped SNPs having strong LD
with the typed SNPs. Second, all three methods found a
substantial number of significant untyped SNPs. Third,
chromosome 6 contains the major histocompatibility
complex (MHC) region and a large number of significant
SNPs were found on this chromosome. However, there
were still a substantial number of significant typed and
untyped SNPs even after excluding significant typed and
untyped SNPs on chromosome 6. We also noticed that
more significant SNPs were found with BIMBAM (201
with BIMBAM versus 43 with IMPUTE). One reason is
that the use of log10(BF) of 3.5 to select significant SNPs
with BIMBAM may not be stringent enough to correct the
multiple testing problem in this situation. The appro-
priate threshold for BF needs to be further investigated.
Fourth, some untyped SNPs were found to be significant
from at least two methods and most of them were on
chromosome 6. When considering the untyped SNPs on
the 21 autosomes (not including chromosome 6), only
36 untyped SNPs were found to be significant by both
BIMBAM and IMPUTE. The set of significant untyped
SNPs identified by IMPUTE and TUNA did not overlap.
Fifth, one may think the inclusion of untyped SNPs in
the test will impose a serious multiple testing problem. It
w a st r u et h a tt h en u m b e ro fs i g n i f i c a n tS N P sw a s
reduced due to the conservative Bonferroni correction
when using imputed SNPs compared to only using typed
SNPs. However, this number was only reduced 17.6% for
IMPUTE (from 428 to 364) and 4.2% for TUNA (from
371 to 356). Given that the follow-up study may only
consider at most the top tens of SNPs, such reduction
will not affect our selection in next step. Sixth, after
excluding SNPs from chromosome 6 for typed SNPs, 44,
55, and 96 SNPs were found to be significant by
BIMBAM, IMPUTE, and TUNA, respectively. Among
them, 8 SNPs were found to be significant by both
BIMBAM and IMPUTE, while 53 SNPs were found to be
significant by both IMPUTE and TUNA. One reason for
differences between BIMBAM and IMPUTE (or TUNA) is
that BIMBAM uses a Bayesian approach that depends on
priors while the tests in IMPUTE and TUNA are only
slightly different from each other. We found 96
significant SNPs with TUNA with p-values similar to
those calculated by IMPUTE. In addition, the p-values of
about 40 SNPs from TUNA were marginally significant
while their p-values were only marginally insignificant
with IMPUTE. Such difference is due to the slightly
different tests for association in TUNA and IMPUTE.
Next, we consider an apparent relationship between the
significant typed and significant untyped SNPs found by
Table 1: Results from the analysis of rheumatoid arthritis data
Number of SNPs Number of Significant SNPs
Methods BIMBAM IMPUTE TUNA BIMBAM IMPUTE TUNA
Results before significant SNPs on chromosome 6 removed
Typed 499,102 515,049 499,084 469 364(428)
a 411(431)
a
Untyped 2,052,389 2,030,768 236,672 2,025 1,230 139
Total 2,551,491 2,545,817 735,756 2,494 1,594 550
Results after significant SNPs on chromosome 6 removed
Typed 465,977 480,591 465,961 44 55(79)
a 96(105)
a
Untyped 1,902,577 1,882,164 217,913 201 43 16
Total 2,368,554 2,362,755 683,874 245 98 112
aFor the number of significant SNPs identified in parentheses, m was set as the number of typed SNPs in the Bonferroni correction.
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majority of untyped SNPs that were significant had
nearby genotyped SNPs that also returned significant
p-values for the same method. Especially for significant
untyped SNPs on chromosome 6, all of them had nearby
significant typed SNPs that were less than 100 kb apart.
This observation indicates that using these methods may
not sufficiently improve power to identify novel genes
associated with RA. Although these SNPs may not be
helpful for identifying novel genes that are associated
with RA from the current study, they may be selected as
candidate SNPs for follow up studies. Nevertheless, each
method still found a few significant SNPs that were
untyped and that are not located near a typed SNP that
w a sa l s of o u n dt ob es i g n i f i c a n t .T h es i g n i f i c a n tu n t y p e d
SNPs that are not located within 2 Mb of a significant
typed SNP are listed in Table 2. Although these SNPs are
not located on any previously identified genes that are
associated with RA, they may be worth further investiga-
tion to identify novel genes associated with RA. For
example, one SNP (rs9434795) located in gene
PLEKHG5 was identified to be significant (p-value =
1.5 × 10
-9) by IMPUTE; a previous study suggested that
PLEKHG5 is associated with lower motor neuron disease
[9]. Another two SNPs, rs4886414 and rs8042558, were
found to be significant with BIMBAM and also had very
small p-values with IMPUTE and TUNA.
The results from BIMBAM and IMPUTE based on
simulation are presented in Table 3 because most of
SNPs were somehow removed from the analysis with
TUNA. For BIMBAM simulations, the thresholds of
log10(BF) were set as log10(7.5) for the CEU samples
and log10(6.5) for the YRI samples. Using these thresh-
olds, BIMBAM had comparable type I error with IMPUTE
using the Bonferroni correction. Several observations
emerged from Table 3. First, the inclusion of untyped
SNPs increased the power when the appropriate refer-
ence samples were used. The imputed MAF at untyped
SNPs was close to the true value and BIMBAM had power
comparable with IMPUTE. Second, the inclusion of
untyped SNPs decreased the power when the inappropri-
a t er e f e r e n c es a m p l e sw e r eu s e d .T h i r d ,t h et y p eIe r r o r
was still maintained for both BIMBAM and IMPUTE even
when the inappropriate reference samples were used.
Discussion
In this paper, we applied three imputation methods,
BIMBAM, IMPUTE, and TUNA to a GWAS of RA data. All
of these methods identified some untyped SNPs that
showed significant association with RA. A few of these are
also not located near a significant typed SNP. This
provides some reason for being selected in follow-up
studiestoidentitynovelgenesthatareassociatedwithRA.
Many imputation-based methods have recently been
proposed, thus it is necessary to compare their strengths
and weaknesses. Indeed, each of these methods has
Table 2: A list of significant untyped SNPs. The significant untyped SNPs that are not located with 2 Mb of any significant typed SNP
log10 (BF) or - log10 (p)( r a n k )
b
Chr. RS Number Distance
a (MB) Gene BIMBAM IMPUTE BIMBAM
15 rs4886414 41.38 SCAMP5 4.07(84)
c 5.53(225) 6.35(24)
15 rs8042558 41.39 PPCDC 4.06(85) 5.53(226) 6.33(27)
2 rs10210993 37.45 MGAT5 3.88(99) 5.13(356) Not Tested
2 rs10170556 37.41 MGAT5 3.82(116) 5.15(352) Not Tested
2 rs2359965 35.03 KLF7 3.57(183) 6.17(102) Not Tested
2 rs1263623 35.04 KLF7 3.57(179) 6.18(100) Not Tested
2 rs1263624 35.03 KLF7 3.57(184) 5.13(358) Not Tested
2 rs2244166 35.03 KLF7 3.55(189) 5.78(176) Not Tested
2 rs2244399 35.03 KLF7 3.54(195) 5.81(173) Not Tested
1 rs9434795 3.13 PLEKHG5 0.94(20368) 9.94(6) Not Tested
21 rs2297248 2 USP25 0.13(162921) 0.02(1817334) 9.04(7)
11 rs7926700 14.32 DYNC2H1 -0.07(518517) 0.72(500481) 7.23(14)
20 rs6017239 4.99 TOX2 -0.08(575887) 0.05(1710287) 9.56(3)
aThe distance to the closet typed SNP that was significant.
bRank is among all untyped SNPs after excluding SNPs on chromosome 6.
cBold font indicates significant SNPs.
Table 3: Type I error, power, and difference between MAF from
imputed and simulated genotypes
Untyped+Typed SNPs Typed SNPs
Sample BIMBAM IMPUTE BIMBAM IMPUTE
CEU Type I 0.021 0.015 0.029 0.031
Power 0.71 0.708 0.537 0.541
Difference 9.6 × 10
-4 6.2 × 10
-4 N/A N/A
YRI Type I 0.032 0.039 0.029 0.033
Power 0.144 0.155 0.176 0.195
Difference 2.43 × 10
-2 2.20 × 10
-2 N/A N/A
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computational efficient because it only uses a small
number of typed SNPs to estimate the genotype
frequencies of the untyped SNPs. Many of the untyped
SNPs were not tested by TUNA. This further increases its
efficiency-TUNA took only about 12 hours to finish all
computations. However, TUNA may miss significant
SNPs. BIMBAM uses Bayesian methods, runs efficiently
and allows for the input and output of zipped files rather
than large text files. The use of BFs has some advantages
over the standard p-value approach [5] but results are not
easily comparable with measures of significance.
IMPUTE has the advantage of allowing the user to
decide the test performed and use imputed genotype
probabilities. However, IMPUTE took more than 400 hours
to complete our computations. Such a heavy computa-
tional demand stands as a roadblock for its general
application in GWAS.
We evaluated their performances in terms of the accuracy
of imputed genotypes and the power and type I error rate
of the subsequent association testing using simulated
data. Our results indicated that when an inappropriate
reference sample is used, the power may decrease but the
type I error rate is maintained. However, when an
appropriate reference sample is used, the genotypes at
untyped SNPs were accurately imputed and the power
w a si n c r e a s e d .T h u s ,i nt h i sc a s e ,i tm a yb ed e s i r a b l et o
use these imputation methods. On the other hand, we
found some untyped SNPs were identified as significant
with one method but not with any of other methods
from the analysis of real data. Therefore, results of
untyped SNPs from these imputation methods must be
used with caution.
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